ADX Labs donates $100,000 to advance COVID-19 vaccine research
June 24, 2020 08:08 ET | ADX Labs, Inc.
The Coalition for Epidemic Preparedness Innovations (CEPI) is accelerating the development of candidate vaccines against COVID-19 with the financial support of Minneapolis-based technology company ADX...
ADX Labs捐赠十万美元,用于推进新冠疫苗研发
June 24, 2020 08:08 ET | ADX Labs, Inc.
总部位于明尼阿波利斯市的科技企业ADX Labs向流行病防范创新联盟(CEPI)慷慨捐款,CEPI将用此笔善款加速新冠病毒候选疫苗的研发工作。 明尼阿波利斯, June 24, 2020 (GLOBE NEWSWIRE) -- ADX Labs向流行病防范创新联盟(CEPI)捐赠10万美元,用于加速新冠疫苗的研发工作。该善款系通过ADX Labs下属的公益机构ADX基金会提供。 ...
Dynavax Announces Collaboration with the University of Queensland and the Coalition for Epidemic Preparedness (CEPI) Focused on the Development of a Coronavirus (COVID-19) Vaccine
March 02, 2020 08:00 ET | Dynavax Technologies Corporation
EMERYVILLE, Calif., March 02, 2020 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today...
CureVac Logo mit Claim RGB.jpg
CEPI awards US$ 34M contract to CureVac to advance The RNA Printer™—a disruptive, transportable mRNA vaccine manufacturing platform that can rapidly combat multiple diseases
February 27, 2019 07:30 ET | CureVac AG
OSLO, Norway, Feb. 27, 2019 (GLOBE NEWSWIRE) -- The Coalition for Epidemic Preparedness Innovations (CEPI) and CureVac AG, a biopharmaceutical company pioneering the field of mRNA-based vaccines,...